Bdf-Gestion
Source: SEC Form 13F · as of Mar 2026Bdf-Gestion holds 14 biotech & pharma companies tracked by BioSniper, totaling $62.9M in value as of Mar 2026 (SEC Form 13F).
Companies held
14
Total value held
$62.9M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 18,702 | $17.2M |
| ABBVAbbVie Inc. | 44,504 | $9.7M |
| MRKMerck & Co., Inc. | 47,224 | $5.7M |
| ABTABBOTT LABORATORIES | 47,296 | $4.9M |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 16,067 | $4.3M |
| CORCencora Inc. | 11,726 | $3.7M |
| GILDGILEAD SCIENCES, INC. | 24,253 | $3.4M |
| GMOptec International, Inc. | 41,043 | $3.1M |
| JNJJOHNSON & JOHNSON | 22,939 | $3.0M |
| BMYBRISTOL MYERS SQUIBB CO | 39,182 | $2.4M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 4,862 | $2.2M |
| ELVElevance Health Inc. | 4,652 | $1.4M |
| RPRXRoyalty Pharma plc | 23,649 | $1.1M |
| MRNAModerna, Inc. | 19,323 | $982K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.